Disseminated salmonellosis in a patient treated with temozolomide

The Journal of Infection
Georgiana GeorgescuKenneth Rolston

Abstract

Temozolomide is a relatively new chemotherapeutic agent frequently associated with selective CD4+ T-lymphocytopenia. Patients with cell-mediated immune defects are at higher risk for acquiring infections with Salmonella species. We describe the first case of disseminated salmonellosis in a patient treated with temozolomide.

References

Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E L Hohmann
Jan 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y B SuPaul B Chapman
Jan 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas F Gajewski
Jan 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew H KulkeCharles S Fuchs
May 14, 2008·The Journal of Infection·Melita A Gordon

❮ Previous
Next ❯

Citations

Aug 2, 2012·Anti-cancer Drugs·Sanjay DixitMohan Hingorani
Feb 1, 2011·The British Journal of Dermatology·T JaegerM D Anliker
Jul 20, 2012·Continuum : Lifelong Learning in Neurology·Morris D Groves, Ava B Plummer
Aug 3, 2010·Journal of Neuro-oncology·Gil Redelman-SidiGenovefa Papanicolaou
May 5, 2010·Journal of Neuro-oncology·Kathleen GrisdaleMorris D Groves

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.